Related Experiment Video
Updated: Jan 19, 2026
10:17
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
7.4K
Obesity and liver cancer
Carlo Saitta1, Teresa Pollicino2, Giovanni Raimondo3
1Division of Clinical and Molecular Hepatology, Department of Internal Medicine, University Hospital of Messina, Italy.
Annals of Hepatology
|September 24, 2019
Summary
Obesity significantly increases the risk of developing liver cancer, particularly hepatocellular carcinoma (HCC). Lifestyle changes like diet and exercise may help reduce this cancer risk.
Area of Science:
- Hepatology
- Oncology
- Public Health
Background:
- Global obesity rates are rising, contributing to significant economic and health burdens.
- Obesity is a major risk factor for type 2 diabetes, cardiovascular diseases, and various cancers.
- Non-alcoholic fatty liver disease (NAFLD), often linked to obesity, is a leading cause of liver disease and hepatocellular carcinoma (HCC).
Purpose of the Study:
- To examine the association between obesity and the increased risk of hepatocellular carcinoma (HCC).
- To explore the role of obesity as a risk factor in non-alcoholic fatty liver disease (NAFLD)-related HCC.
- To discuss the potential impact of lifestyle interventions on reducing HCC risk in obese individuals.
Main Methods:
- Review of epidemiological data and clinical studies on obesity and liver cancer.
- Analysis of the prevalence of obesity in patients with NAFLD and HCC.
- Examination of the impact of obesity on HCC screening, diagnosis, and treatment outcomes.
Main Results:
- Obesity is an independent risk factor for HCC development, especially in the context of NAFLD.
- NAFLD-related HCC is a rapidly growing indication for liver transplantation.
- Obese HCC patients may experience higher mortality due to poorer treatment outcomes and delayed diagnosis from suboptimal screening.
Conclusions:
- Obesity significantly elevates the risk of HCC, acting as a co-factor in chronic liver diseases.
- Healthy diet and regular physical activity are crucial for mitigating HCC risk.
- Further research is needed to confirm the link between obesity and intrahepatic cholangiocarcinoma.
Keywords:
Hepatocellular carcinomaIntrahepatic cholangiocarcinomaNon-alcoholic fatty liver diseaseNon-alcoholic steatohepatitisObesityMore Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
6.0K
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
1.7K
Related Concept Videos
01:24Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
249
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
249
01:24Overview of Lipid Metabolism
4.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.9K
01:26Diseases of the Liver and Gallbladder
1.9K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.9K
01:21Drug Dosing: Obese Patients
227
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
227